Skip to main content
. 2017 May 12;7(2):505–513. doi: 10.1177/2045893217706691

Fig. 1.

Fig. 1.

Patient disposition. x/y values indicate that x participants were treated in the sequence I-Neb–BREELIB and y in the sequence BREELIB–I-Neb. AE, adverse event.